| Literature DB >> 2591993 |
D Cox1, R O'Kennedy, R D Thornes.
Abstract
1. Two thousand, one hundred and seventy-three patients with cancer or chronic infections were treated with coumarin in a clinical trial. 2. 0.37% of these patients developed elevated liver enzyme levels during therapy with coumarin. 3. This hepatitis was probably a form of idiosyncratic hepatotoxicity and may have been immune in origin.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2591993 DOI: 10.1177/096032718900800612
Source DB: PubMed Journal: Hum Toxicol ISSN: 0144-5952